PRE-WORKSHOP MATERIALS AND EVENTS
- Workshop Pretest
- Completed online between July 9-11
- Completed online between July 9-11
- JULY 12, Pre-recorded lectures become available on-demand
- Lecture Session 1
- Clinical Trial Design: Asking Important Questions that Impact Our Patients
- Julie M. Vose, University of Nebraska Medical Center, Omaha, NE
- Answering Important Questions: From Hypothesis to Analysis
- Thomas M. Braun, University of Michigan, Ann Arbor, MI
- Phase I Trial Questions
- Manuel Hidalgo, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY
- Phase I Trial Designs
- Nolan M. Wages, University of Virginia, Charlottesville, VA
- Nolan M. Wages, University of Virginia, Charlottesville, VA
- Clinical Trial Design: Asking Important Questions that Impact Our Patients
- Lecture Session 2
- Phase II Trial Questions/Objectives
- Maha Hussain, Northwestern University, Chicago, IL
- Phase II Trial Designs
- Sean Devlin, Memorial Sloan Kettering Cancer Center, New York, NY
- Combination and Multimodality Trials
- Yelena Janjigian, Memorial Sloan Kettering Cancer Center, New York, NY
- Yelena Janjigian, Memorial Sloan Kettering Cancer Center, New York, NY
- Phase II Trial Questions/Objectives
- Lecture Session 3
- Feasibility and Reproducibility in Biomarker Studies
- Timothy A. Yap, The University of Texas MD Anderson Cancer Center, Houston, TX
- Statistical Aspects of Correlative Studies
- Wendy B. London, Boston Children’s Hospital/Dana-Farber Cancer Institute, Boston, MA
- Wendy B. London, Boston Children’s Hospital/Dana-Farber Cancer Institute, Boston, MA
- Feasibility and Reproducibility in Biomarker Studies
- Lecture Session 4
- Imaging in the Era of Targeted Therapy and Immunotherapy
- Thomas E. Yankeelov, The University of Texas, Austin, TX
- Special Considerations in the Design of Immunotherapy Studies
- Roy S. Herbst, Yale Cancer Center, New Haven, CT
- Roy S. Herbst, Yale Cancer Center, New Haven, CT
- Imaging in the Era of Targeted Therapy and Immunotherapy
- Lecture Session 5
- Research Challenges in the era of COVID
- Laura Michaelis, Medical College of Wisconsin, Milwaukee, WI
- Patient Reported Outcomes
- Karyn Goodman, Icahn School of Medicine at Mount Sinai, New York, NY
- Karyn Goodman, Icahn School of Medicine at Mount Sinai, New York, NY
- Research Challenges in the era of COVID
- Lecture Session 6
- You’re in Charge: Investigator Responsibilities and Ethical Conduct of Research
- Manish A. Shah, Weill Cornell Medical College, New York, NY
- Informed Consent
- Josh Mailman, NorCal CarciNET Community, Oakland, CA
- Josh Mailman, NorCal CarciNET Community, Oakland, CA
- You’re in Charge: Investigator Responsibilities and Ethical Conduct of Research
- Lecture Session 7
- Data Collection and Reporting: It’s All in the Data
- Mark Krailo, Children’s Oncology Group, Arcadia, CA
- Inclusivity in Clinical Trials
- Stuart M. Lichtman, Memorial Sloan Kettering Cancer Center, New York, NY
- Stuart M. Lichtman, Memorial Sloan Kettering Cancer Center, New York, NY
- Data Collection and Reporting: It’s All in the Data
- Lecture Session 1
LIVE VIRTUAL EVENTS
July 26, 2021
Welcome from the Co-directors
11-11:05 am ET
Lecture Session 1 Q&A
11:05-11:40 am ET
Introduction: Ivy B. Elkins, EGFR Resisters, Evanston, IL
Thomas M. Braun, University of Michigan, Ann Arbor, MI
Manuel Hidalgo, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY
Julie M. Vose, University of Nebraska Medical Center, Omaha, NE
Nolan M. Wages, University of Virginia, Charlottesville, VA
Break
11:40-11:45 am ET
Lecture Session 2 Q&A
11:45 am-12:30 pm ET
Introduction: Josh Mailman, NorCal CarciNET Community, Oakland, CA
Sean Devlin, Memorial Sloan Kettering Cancer Center, New York, NY
Maha Hussain, Northwestern University, Chicago, IL
Yelena Janjigian, Memorial Sloan Kettering, New York, NY
Break
12:30 -1 pm ET
Protocol Development Group 1
1-2:30 pm ET
Break
2:30-3 pm ET
Protocol Development Group 1 (continued)
3-4:30 pm ET
Office Hours 1: Protocol and Statistical Related Questions
5-6:30 pm ET
Independent Study Time
4:30-6:30 pm ET
ASSIGNMENT DUE: PROTOCOL TEMPLATE
7 pm ET
July 27, 2021
Faculty Meeting (Faculty Only)
10-11 am ET
Lecture Session 3 Q&A
11-11:40 am ET
Timothy A. Yap, The University of Texas MD Anderson Cancer Center, Houston, TX
Wendy B. London, Boston Children’s Hospital/Dana-Farber Cancer Institute, Boston, MA
Break
11:40-11:45 am ET
Lecture Session 4 Q&A
11:45 am-12:30 pm ET
Introduction: Carole Baas, Physical Sciences in Oncology Network, Rockville, MD
Roy S. Herbst, Yale Cancer Center, New Haven, CT
Thomas E. Yankeelov, The University of Texas, Austin, TX
Protocol Development Group Session 2
1-3 pm ET
Office Hours 2/Independent Study Time
3:30-6:30 pm ET
ASSIGNMENT DUE: STATISTICAL DESIGN
7 pm
July 28, 2021
Lecture Session 5-6 Q&A
11-11:40 am ET
Introduction: Laurel Pracht, NRG Oncology, Philadelphia, PA
Karyn Goodman, Icahn School of Medicine at Mount Sinai, New York, NY
Josh Mailman, NorCal CarciNET Community, Oakland, CA
Laura Michaelis, Medical College of Wisconsin, Milwaukee, WI
Manish A. Shah, Weill Cornell Medical College, New York, NY
Break
11:40-11:45 am ET
Lecture Session 7 Q&A
11:45 am-12:30 pm ET
Introduction: Pamela R. Moffitt, Alliance for Clinical Trial in Oncology, Boston, MA
Stuart M. Lichtman, Memorial Sloan Kettering Cancer Center, New York, NY
Mark Krailo, Children’s Oncology Group, Arcadia, CA
Protocol Development Group Session 3
1-3 pm ET
Office Hours 3/Independent Study Time
3:30-6:30 pm ET
ASSIGNMENT DUE: DRAFT PROTOCOL
7 pm ET
July 29, 2021
Protocol Development Group Session 4
11 am-12:30 pm ET
Administration of Post-test
1:30-2:30 pm ET
Faculty Meeting (Faculty Only)
2:30-3:30 pm ET
ASSIGNMENT DUE: FINAL PROTOCOLS, INFORMED CONSENT FORMS
7 pm ET
ALL WORKSHOP EVALUATIONS DUE
11:59 pm ET
July 30, 2021
Final PDG Evaluations from Faculty Due
5 pm ET